Background-Current risk models for predicting long-term mortality after percutaneous coronary intervention are restricted to all-cause mortality. We sought to develop novel risk models for the prediction of cardiac and noncardiac mortality after percutaneous coronary intervention. Methods and Results-We retrospectively evaluated patients who underwent index percutaneous coronary intervention at Mayo Clinic from 2003 to 2008. Long-term deaths were ascertained through scheduled prospective surveillance. Cause of death was determined via telephone interviews, medical records, and autopsy reports. Fine and Gray extension of Cox proportional hazards models was used to model cause-specific cumulative incidence. Candidate variables and interactions were chosen a priori, without variable selection methods. Resulting models were mapped to an integer-based risk score. The study comprised 6636 patients followed up over a median of 62 months (25th, 75th percentiles: 45, 77 months). There were 1488 deaths, 518 (35%) cardiac, 938 (63%) noncardiac, and 32 (2%) unknown. The 5-year predicted cardiac mortality ranged from 0.6% to 97%, with a corrected c-statistic of 0.82. Risk factors for cardiac death included age, body mass index, ejection fraction, and history of congestive heart failure. The integer score for noncardiac death included age, medicine index, body mass index, current smoker, noncardiac Charlson index and cardiac Charlson index, and accommodated significant age-based interactions for smoking and the 2 Charlson indices. Predicted noncardiac mortality at 5 years ranged from 0.2% to 81%, with a corrected c-statistic of 0.77. Conclusions-We report novel risk models to predict cardiac and noncardiac long-term mortality after percutaneous coronary intervention. (Circ Cardiovasc Interv. 2015;8:e002121.
R isk models for the prediction of long-term mortality after percutaneous coronary intervention (PCI) can assist with clinical decision making, targeting of care, and assessment of outcomes data in a risk-adjusted manner. [1] [2] [3] [4] Currently available risk models for predicting long-term mortality are derived using data from either registries [5] [6] [7] [8] [9] or randomized controlled trials. [10] [11] [12] All currently available risk tools predict all-cause rather than cause-specific mortality.
In a large single-center study, we recently demonstrated that over the past 2 decades, there has been a marked temporal shift in cause of long-term death after PCI. 13 Although historically the majority of long-term deaths were comprised cardiac fatalities, in the contemporary era, only 37% of deaths at 5 years after index PCI hospitalization were from cardiac causes. The most frequent individual causes of death were cancer and chronic diseases.
The potential impact of these major temporal changes in causes of death are far reaching and underscore the need to develop tools for the prediction of cause specific (cardiac and noncardiac) rather than all-cause mortality after PCI. Such risk tools will serve to enhance postprocedural targeting of care. The competing risk of cardiac versus noncardiac comorbidities among a burgeoning older population has a major impact on outcomes of PCI and plays a role in the appropriate utilization of PCI. In addition, these models can be used to help guide patient selection for clinical trials and play a role in statistical modeling for observational studies. Accordingly, using contemporary, prospectively collected, single-center registry data, we aimed to develop simple risk models from
Definitions
Definitions for 17 disease components of the Charlson index were previously described by Deyo et al. 14 The Charlson index was split into cardiac (history of myocardial infarction and history of congestive heart failure) and noncardiac components (including malignant, pulmonary, endocrine, neurological, vascular infectious, and rheumatologic variables (Table I in the Data Supplement) . For predismissal medications, a medication score was assigned to each patient based on the medications at discharge from the hospital. One point is added to the medication score for each of the following medication classes: antiplatelets (aspirin), β-blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering agents. Therefore, a medication score of 0 means that the patient was discharged on none of these medication classes, and a medication score of 4 means that they were discharged on all 4 of them. Additional definitions are supplied in the Data Supplement.
Ascertainment of Death and Determination of Cause
Ascertainment and adjudication of cause of death in this data set have been previously described. 13 In brief, deaths were ascertained via scheduled telephone contact of all patients performed routinely at 6 months, 12 months, and yearly after first PCI hospitalization till death. After a patient death was identified, cause was determined through telephone contact with family and external providers, as well as through review of medical records (local/external). Death certificates were requested for all patients. When cause of death could not initially be ascertained (≈10%), information was obtained from the National Death Index. Experienced data technicians performed the initial classification of cause of death into cardiac and noncardiac categories. Two physicians performed secondary review of each initial classification, rescreened medical records where appropriate, resolved disparity by consensus, and performed final categorization.
Statistical Methods
Continuous variables are summarized as mean±SD, unless otherwise noted. Categorical variables are presented as frequency (percentage). Time to event was defined as the days from discharge after PCI to date of death (or last known alive date). If patients had multiple qualifying PCIs before an event, the model variables from the subsequent PCIs were included in the model using time-dependent covariates. The values of the explanatory variables were changed at the time since the first PCI. In this way, events were not double counted, and information from multiple PCIs was not discarded.
To avoid overfitting, risk factors for each end point were prespecified. Table 1 lists variables prespecified for the 2 end points. Three
WHAT IS KNOWN
• Over the past 2 decades, there has been a temporal switch from predominantly cardiac to predominantly noncardiac causes of long-term death after percutaneous coronary intervention.
• There are currently no risk models that predict cause-specific mortality after percutaneous coronary intervention.
WHAT THE STUDY ADDS
• Using contemporary, prospectively collected registry data, we developed risk models to predict cardiac and noncardiac long-term mortality after percutaneous coronary intervention.
• These models could be used to enhance postprocedural targeting of care and to guide percutaneous coronary intervention research methodology. 15 Of the variables selected for modeling, ejection fraction was 16 The prespecified main effects were modeled to the cause-specific subdistribution hazards using Fine and Gray extension of the Cox multiple regression model for each multiple imputation data set. 17 SAS procedure PHREG with the EVENTCODE option was used to fit Fine and Gray models. We evaluated Schoenfeld residuals to assess the proportional hazards assumption (Data Supplement). Splines were used to model the associations between continuous variables and the subhazard. Prespecified interactions also were included. Shrinkage estimates were used to indicate the possibility of overfitting and guide possible variable selection (more details are available in the Data Supplement). In addition, a single likelihood ratio test was calculated for all interactions. If this test was significant, then all interactions were retained; otherwise, all interactions were removed.
Parameter estimates were combined from the imputation models by means of Rubin rules. 18 Integer scores were developed by dividing the model parameter estimates by a divisor (D) chosen such that all statistically significant variables have a nonzero contribution toward the integer score and so that the range of risk scores would be <25. We started with a D<1 and a multiple of 0.01 and iterated downward by steps of 0.01 until we found a D that met the criteria. Thus, at each iteration for each patient, we calculated an array of integer summands by dividing the parameter estimates by D and rounding to the nearest integer, then summing to the integers to get the estimated integer score. For variables modeled nonlinearly as splines, we added all spline effects together first and then divided by D. Once we found a range of divisors meeting the criteria, we inspected the correlation between the resulting integer scores and the linear predictor from the model. We chose a D that maximized the correlation while still meeting the restriction on the range of scores. The use of splines and interactions in the model for noncardiac mortality occasionally resulted in clinically unexpected weights at extreme ages (eg, a protective effect for smoking in young patients). Integer mapping at these extremes was constrained so that smoking could not have a protective effect, and so that within a given age group, additional comorbidities resulted in additional (or equal) risk.
Fine and Gray models were used to estimate the expected 1-and 5-year event rates for the integer scores. Cumulative incidence estimates in the presence of competing risks were used to obtain the observed rates by integer score. 19 The discriminatory ability of the score was assessed by the modified c-statistic. 20 The scores were internally validated by correcting the c-statistic for optimism bias. Two hundred bootstrap samples were created, and models were reestimated and the applied to the original data set to estimate the optimism in the c-statistic. The bias-corrected c-statistic was estimated by subtracting the estimated optimism from the unadjusted c-statistic. All P values are 2 tailed at a 0.05 significance level. All analyses were conducted using SAS 9.4 software (SAS Institute, Cary, NC).
Results
The analysis data set comprised 6636 PCI patients over the 6-year study period. Two hundred eight who refused the use of their records for research were excluded. The average age was 66 years, and 69% were men. Patients were followed up for a median (25th, 75th percentiles) of 6.0 (4.3, 7.2) years. During follow-up, 1488 deaths were observed, of which 518 were classified as having cardiac causes, 938 as noncardiac, and 32 of unknown cause. Figure 1 shows the cumulative incidence over time for both cardiac and noncardiac cause mortality. Table 2 summarizes the patient characteristics further and provides unadjusted hazard ratios for cardiac and noncardiac deaths for those risk factors.
Statistical Model for Cardiac Death
The test for interactions in the model for cardiac death was nonsignificant, and thus no interactions were included in the final model. The estimated hazard ratios from the proportional hazards model for cardiac death are available in Table II in the Data Supplement. The shrinkage estimate of the final model was 96%, indicating that the model is not overfit and should generalize well to similar populations.
The scoring system resulting from the model for cardiac death is shown in Table 3 , along with the expected 1-and 5-year rates for the resulting score. Figure 2 and Figures I and II in the Data Supplement compare the expected rates from the score versus the observed rates within the data set. Extreme scores are not shown in Figure 2 because of low sample size (98.6% scored within −1 to 13). The plot shows generally good calibration between observed and expected rates, with perhaps some underestimation of 5-year cardiac mortality at scores of 8 to 10. The raw c-statistic for the model is 0.823; the bias-corrected c-statistic from bootstrapping is 0.820.
Statistical Model for Noncardiac Death
The overall test for interactions in the model for noncardiac deaths was statistically significant (P<0.001), thus the 3 interaction effects (24 parameters) were retained in the full model. The estimated hazard ratios from the proportional hazards model for noncardiac death are shown in Table III in the Data Supplement. The shrinkage estimate of the final model was 96%.
The scoring system resulting from the model of noncardiac death is shown in Table 4 , along with the expected 1-and 5-year rates for the resulting score. Figure 3 and Figures III and IV in the Data Supplement compare the expected rates from the score versus the observed rates within the data set. Scores outside the range of 4 to 18 are not shown in Figure 3 because of low numbers outside that range (98.4% scored within [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . The plot shows general agreement between observed and expected rates, with some overestimation of 5-year risk at scores of 7 to 9. The raw c-statistic for the model is 0.773; the bias-corrected c-statistic from bootstrapping is 0.769.
Performance in Selected Subgroups
We evaluated the predicted rate of events (cardiac and noncardiac death) at 1 and 5 years when compared with observed event rates in 13 different subgroups (Table IV in the Data Supplement). In general, observed and expected event rates were similar. The score for cardiac death slightly overestimated the risk at 5 years in those with single-vessel disease (expected 4.7% versus observed 3.3%) and in elective PCI (6.8% versus 5.7%). All other 5-year expected rates of cardiac death were within 1% of the observed rate. The score for noncardiac death underestimated the 5-year risk in patients with a history of congestive heart failure (expected 18.5% versus observed 21.5%). All other 5-year expected rates of noncardiac death were within 1% of the observed rate.
Discussion
The current study describes novel risk models, derived from contemporary registry data, for the prediction of cause-specific (cardiac and noncardiac) long-term mortality after PCI. These models, created from readily obtainable clinical and angiographic variables, have demonstrated good discriminatory ability and accuracy and for the first time allow for the accurate prediction of long-term cause-specific mortality in patients undergoing PCI.
Previous risk models aimed at predicting long-term mortality after PCI are limited to all-cause mortality, [6] [7] [8] [9] [10] [11] [12] which historically served as a relevant and reasonable surrogate for cardiac mortality given the preponderance of cardiac causes of death. 21 However, the past 2 decades have witnessed a striking shift from predominantly cardiac to noncardiac causes of long-term death after PCI. 13 The reduction in cardiac deaths has likely been because of improvements in preventative therapies and revascularization technologies, whereas the increase in noncardiac deaths has likely resulted from an increase in the prevalence of noncardiac comorbidities at baseline as a consequence, in part, of a burgeoning elderly population and also extension of PCI to patients at higher risk. 13 Thus, in the contemporary era of PCI, all-cause mortality may be a less useful end point for risk prediction models. The present study, which describes cause-specific long-term mortality models, will serve to provide enhanced clinical utility in the current era of PCI. The models have roles in 2 broad applications: (1) clinical care and (2) clinical trials and outcomes research.
Clinical Implications

Postprocedural Setting
Although cardiac mortality after PCI has declined, the competing risk of noncardiac mortality has increased over time because of the prevalence of comorbidities in an older, sicker population being treated with PCI. 13, 22 Thus, a risk model to predict death from noncardiac diseases after PCI hospitalization is of particular importance in the current era: first, to assist in identification of those who may derive particular benefit from collaborative, multidisciplinary care in attempts to reduce long-term mortality from noncardiac diseases. A second, more specific use for the model might be to help individualize the duration of dual antiplatelet therapy after PCI. Recent data have suggested that prolonged dual antiplatelet therapy (beyond 1 year) is associated with a higher risk of noncardiac mortality, offsetting potential benefits of reduced cardiac event rates. 23, 24 The models described in the current study could thus facilitate a patient-specific approach to the recommended duration of dual antiplatelet therapy, based on calculated risks of long-term cardiac and noncardiac deaths.
It seems reasonable to consider that identification of patients at highest risk for cardiac mortality after PCI might benefit from enhanced targeting of cardiac-specific therapies. Such strategies might, for example, include more aggressive secondary preventative pharmacotherapies, pursuit of completeness of revascularization, or even earlier implantation of cardiac defibrillators. Importantly, however, these riskdirected approaches remain to be tested in the clinical setting.
Preprocedural Setting
Previous PCI models predicting all-cause mortality have described their applicability in the preprocedural evaluation of patients being considered for PCI. [5] [6] [7] [8] [9] However, it is important to recognize that these models, in addition to the current model, only strictly apply to patients who have survived to dismissal after successful PCI. Thus, caution needs to be applied if any such models are used for shared decision making and patient selection before PCI. 
